Hercules Technology Growth Capital (HTGC) 15.49 $HTGC
Melinta Therapeutics Secures up to $30 Million from Hercules Technology Growth Capital
GlobeNewswire - Mon Feb 09, 7:06AM CST
Melinta Therapeutics announced today that it has entered into a $30 million growth capital debt financing agreement with Hercules Technology Growth Capital, Inc. (NYSE:HTGC). The initial funding of $20 million closed in December 2014. Melinta has the option, under the terms of the agreement, to draw an additional $10 million tranche in 2015 upon achievement of certain milestones. The capital raised from this financing will be used to advance Melinta's pipeline, which includes delafloxacin, an investigational fluoroquinolone undergoing a confirmatory Phase 3 study for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI), and to repay an existing term loan and for general corporate purposes.
HTGC: 15.49 (+0.04)
BDC Performance Since 2013
BDC Buzz - at Seeking Alpha - Sun Feb 08, 3:31AM CST
NMFC: 14.83 (+0.01), PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), TCAP: 22.52 (+0.37), SLRC: 19.24 (+0.02), BKCC: 8.50 (+0.09), FULL: 4.40 (+0.06), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), PFLT: 13.73 (-0.07), GLAD: 7.77 (-0.01), TCPC: 16.39 (+0.17), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), PSEC: 8.67 (+0.07), FSIC: 9.49 (+0.03)
This Unique New High Dividend Stock Will Yield 12%-Plus In 2015
Double Dividend Stocks - at Seeking Alpha - Sat Jan 31, 2:17PM CST
MAIN: 30.82 (+0.23), HTGC: 15.49 (+0.04), TCAP: 22.52 (+0.37), NEWT: 15.13 (-0.12), KCAP: 7.04 (+0.09)
Hercules Technology Growth Capital declares record gain of USD23.0m with closure of Box Inc's IPO
M2 - Fri Jan 30, 2:12AM CST
Hercules Technology Growth Capital Inc (NYSE:HTGC), a speciality finance company, on Thursday disclosed a potential record unrealised gain of about USD23.0m from the initial public offering of the Box Inc (NYSE:BOX), completed on 23 January 2015.
BOX: 20.18 (+0.01), HTGC: 15.49 (+0.04)
Aspire Bariatrics Secures $12 Million Venture Loan Facility with Hercules Technology Growth Capital
PR Newswire - Thu Jan 29, 3:30PM CST
Aspire Bariatrics, a medical device company developing and commercializing a reversible minimally-invasive weight loss device for obesity, announced today that it has closed on up to $12 million in venture debt financing with Hercules Technology Growth Capital (NYSE: HTGC). The financing will support the continuation of the company's PATHWAY pivotal trial in the US and Pre-Market Application (PMA) filing, expected in mid-2015. The financing will also support ongoing post-market studies for the device, which is currently approved for commercial sale in Europe.
HTGC: 15.49 (+0.04)
Hercules Technology Growth Capital Announces a Record Unrealized Gain of ~$23.0 Million through the Successful Completion of the Box, Inc. IPO, as of January 28, 2015
Business Wire - Wed Jan 28, 4:59PM CST
--Hercules currently holds over 120 additional warrant and equity positions which represent the potential for additional future gains in our venture growth investment portfolio
HTGC: 15.49 (+0.04), BOX: 20.18 (+0.01), ZSAN: 11.00 (-0.01)
Top 10 BDC Issues For 2015: Survey Results Part 2
BDC Buzz - at Seeking Alpha - Mon Jan 26, 11:22PM CST
PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), TCAP: 22.52 (+0.37), BKCC: 8.50 (+0.09), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), PFLT: 13.73 (-0.07), GLAD: 7.77 (-0.01), TCRD: 11.75 (+0.23), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCGC: 3.84 (-0.01), TSLX: 17.78 (+0.07), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), FDUS: 16.04 (+0.14), PSEC: 8.67 (+0.07)
BIND Therapeutics amends and increases existing USD3m credit facility with Hercules Technology III
M2 - Mon Jan 26, 4:16AM CST
Nanomedicine company BIND Therapeutics (BIND) reported on Friday an amendment to its existing credit facility with Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital (NYSE:HTCG).
HTGC: 15.49 (+0.04), BIND: 6.06 (+0.21)
BIND Therapeutics Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth
Business Wire - Fri Jan 23, 4:00PM CST
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins(TM), announced today that it has entered into an amendment of its existing credit facility from Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital (NYSE: HTCG). Under the amendment, the company borrowed an additional $15 million in growth capital, less the repayment of the outstanding balance on BIND's existing term loan facility of approximately $3 million.
HTGC: 15.49 (+0.04), BIND: 6.06 (+0.21)
Oil And Energy Exposure For BDCs
BDC Buzz - at Seeking Alpha - Tue Jan 20, 4:10AM CST
PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), BKCC: 8.50 (+0.09), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), HRZN: 14.22 (+0.16), PFLT: 13.73 (-0.07), GLAD: 7.77 (-0.01), TCPC: 16.39 (+0.17), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), PSEC: 8.67 (+0.07)
Assessing Risk Versus Reward For High Yield BDCs
John Dowdee - at Seeking Alpha - Sun Jan 18, 1:59AM CST
MAIN: 30.82 (+0.23), HTGC: 15.49 (+0.04), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), BDCS: 22.99 (+0.10), PSEC: 8.67 (+0.07)
Top 10 BDC Issues For 2015: Part 6
BDC Buzz - at Seeking Alpha - Wed Jan 14, 4:41AM CST
NMFC: 14.83 (+0.01), PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), TCAP: 22.52 (+0.37), SLRC: 19.24 (+0.02), FULL: 4.40 (+0.06), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), HRZN: 14.22 (+0.16), PFLT: 13.73 (-0.07), TCPC: 16.39 (+0.17), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCGC: 3.84 (-0.01), TSLX: 17.78 (+0.07), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), FDUS: 16.04 (+0.14), PSEC: 8.67 (+0.07), FSIC: 9.49 (+0.03)
3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Jan 10, 1:07PM CST
Source: Flickr via Idaho National Laboratory. Biotech stocks have the uncanny ability to absolutely crush it following a positive clinical or regulatory catalyst. And this trend has been especially pronounced among standout clinical-stage...
BLUE: 90.70 (+0.93), DVAX: 16.96 (+0.66), HTGC: 15.49 (+0.04), NVAX: 8.80 (+0.40), PFE: 34.64 (-0.23), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), CLDN: 16.45 (-0.05), GSK: 47.94 (+1.99)
Will Hercules Technology's Enhanced Investments Pay Off? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 09, 3:00PM CST
On Jan 5, 2015, we issued an updated research report on Hercules Technology (HTGC).
HTGC: 15.49 (+0.04), FULL: 4.40 (+0.06), ARCC: 16.85 (+0.01), GARS: 14.77 (+0.08)
Cerulean Secures Debt Facility from Hercules Technology Growth Capital of Up to $26.0 Million
Business Wire - Thu Jan 08, 3:00PM CST
Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting(TM), today announced that it has entered into a loan and security agreement with Hercules Technology Growth Capital, Inc. (NYSE:HTGC) for a term loan of up to $26.0 million and completed a private placement for $1.0 million of Cerulean common stock with Hercules.
HTGC: 15.49 (+0.04), CERU: 6.62 (-0.06)
Egalet Acquires/Licenses Two Innovative Approved Pain Products
GlobeNewswire - Thu Jan 08, 7:50AM CST
--Transactions transform Egalet into a commercial specialty pharmaceutical company paving the way for commercialization of late-stage pipeline of abuse-deterrent opioids --
EGLT: 10.60 (+0.58), HTGC: 15.49 (+0.04)
Hercules Technology Growth meets stock trading price conversion requirement for senior notes due 2016
M2 - Thu Jan 08, 4:17AM CST
Speciality finance company Hercules Technology Growth Capital Inc (NYSE:HTGC) disclosed on Thursday that it notified the holders of its 6.00% convertible senior notes due 2016 that the stock trading price conversion requirement was met, during the three months ended 31 December 2014.
HTGC: 15.49 (+0.04)
Hercules Technology Growth Capital Announces the Continued Convertibility of Its 6.00% Convertible Senior Notes Due 2016 Through March 31, 2015
Business Wire - Wed Jan 07, 3:05PM CST
Hercules Technology Growth Capital, Inc. (NYSE:HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology, at all stages of development, today announced that holders of its 6.00% Convertible Senior Notes due 2016 have been notified that the stock trading price conversion requirement was met during the three months ended December 31, 2014.
HTGC: 15.49 (+0.04)
Melinta Therapeutics Secures up to $30 Million from Hercules Technology Growth Capital
GlobeNewswire - Mon Feb 09, 7:06AM CST
Melinta Therapeutics announced today that it has entered into a $30 million growth capital debt financing agreement with Hercules Technology Growth Capital, Inc. (NYSE:HTGC). The initial funding of $20 million closed in December 2014. Melinta has the option, under the terms of the agreement, to draw an additional $10 million tranche in 2015 upon achievement of certain milestones. The capital raised from this financing will be used to advance Melinta's pipeline, which includes delafloxacin, an investigational fluoroquinolone undergoing a confirmatory Phase 3 study for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI), and to repay an existing term loan and for general corporate purposes.
HTGC: 15.49 (+0.04)
BDC Performance Since 2013
BDC Buzz - at Seeking Alpha - Sun Feb 08, 3:31AM CST
NMFC: 14.83 (+0.01), PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), TCAP: 22.52 (+0.37), SLRC: 19.24 (+0.02), BKCC: 8.50 (+0.09), FULL: 4.40 (+0.06), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), PFLT: 13.73 (-0.07), GLAD: 7.77 (-0.01), TCPC: 16.39 (+0.17), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), PSEC: 8.67 (+0.07), FSIC: 9.49 (+0.03)
This Unique New High Dividend Stock Will Yield 12%-Plus In 2015
Double Dividend Stocks - at Seeking Alpha - Sat Jan 31, 2:17PM CST
MAIN: 30.82 (+0.23), HTGC: 15.49 (+0.04), TCAP: 22.52 (+0.37), NEWT: 15.13 (-0.12), KCAP: 7.04 (+0.09)
Hercules Technology Growth Capital declares record gain of USD23.0m with closure of Box Inc's IPO
M2 - Fri Jan 30, 2:12AM CST
Hercules Technology Growth Capital Inc (NYSE:HTGC), a speciality finance company, on Thursday disclosed a potential record unrealised gain of about USD23.0m from the initial public offering of the Box Inc (NYSE:BOX), completed on 23 January 2015.
BOX: 20.18 (+0.01), HTGC: 15.49 (+0.04)
Aspire Bariatrics Secures $12 Million Venture Loan Facility with Hercules Technology Growth Capital
PR Newswire - Thu Jan 29, 3:30PM CST
Aspire Bariatrics, a medical device company developing and commercializing a reversible minimally-invasive weight loss device for obesity, announced today that it has closed on up to $12 million in venture debt financing with Hercules Technology Growth Capital (NYSE: HTGC). The financing will support the continuation of the company's PATHWAY pivotal trial in the US and Pre-Market Application (PMA) filing, expected in mid-2015. The financing will also support ongoing post-market studies for the device, which is currently approved for commercial sale in Europe.
HTGC: 15.49 (+0.04)
Hercules Technology Growth Capital Announces a Record Unrealized Gain of ~$23.0 Million through the Successful Completion of the Box, Inc. IPO, as of January 28, 2015
Business Wire - Wed Jan 28, 4:59PM CST
--Hercules currently holds over 120 additional warrant and equity positions which represent the potential for additional future gains in our venture growth investment portfolio
HTGC: 15.49 (+0.04), BOX: 20.18 (+0.01), ZSAN: 11.00 (-0.01)
Top 10 BDC Issues For 2015: Survey Results Part 2
BDC Buzz - at Seeking Alpha - Mon Jan 26, 11:22PM CST
PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), TCAP: 22.52 (+0.37), BKCC: 8.50 (+0.09), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), PFLT: 13.73 (-0.07), GLAD: 7.77 (-0.01), TCRD: 11.75 (+0.23), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCGC: 3.84 (-0.01), TSLX: 17.78 (+0.07), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), FDUS: 16.04 (+0.14), PSEC: 8.67 (+0.07)
BIND Therapeutics amends and increases existing USD3m credit facility with Hercules Technology III
M2 - Mon Jan 26, 4:16AM CST
Nanomedicine company BIND Therapeutics (BIND) reported on Friday an amendment to its existing credit facility with Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital (NYSE:HTCG).
HTGC: 15.49 (+0.04), BIND: 6.06 (+0.21)
BIND Therapeutics Amends Credit Facility from Hercules Technology III, L.P. to Accelerate Accurin Pipeline Growth
Business Wire - Fri Jan 23, 4:00PM CST
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins(TM), announced today that it has entered into an amendment of its existing credit facility from Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital (NYSE: HTCG). Under the amendment, the company borrowed an additional $15 million in growth capital, less the repayment of the outstanding balance on BIND's existing term loan facility of approximately $3 million.
HTGC: 15.49 (+0.04), BIND: 6.06 (+0.21)
Oil And Energy Exposure For BDCs
BDC Buzz - at Seeking Alpha - Tue Jan 20, 4:10AM CST
PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), BKCC: 8.50 (+0.09), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), HRZN: 14.22 (+0.16), PFLT: 13.73 (-0.07), GLAD: 7.77 (-0.01), TCPC: 16.39 (+0.17), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), PSEC: 8.67 (+0.07)
Assessing Risk Versus Reward For High Yield BDCs
John Dowdee - at Seeking Alpha - Sun Jan 18, 1:59AM CST
MAIN: 30.82 (+0.23), HTGC: 15.49 (+0.04), ARCC: 16.85 (+0.01), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), BDCS: 22.99 (+0.10), PSEC: 8.67 (+0.07)
Top 10 BDC Issues For 2015: Part 6
BDC Buzz - at Seeking Alpha - Wed Jan 14, 4:41AM CST
NMFC: 14.83 (+0.01), PNNT: 9.40 (+0.16), HTGC: 15.49 (+0.04), MAIN: 30.82 (+0.23), TCAP: 22.52 (+0.37), SLRC: 19.24 (+0.02), FULL: 4.40 (+0.06), TICC: 7.54 (+0.04), SUNS: 15.79 (-0.05), GBDC: 17.51 (-0.06), HRZN: 14.22 (+0.16), PFLT: 13.73 (-0.07), TCPC: 16.39 (+0.17), FSC: 7.23 (+0.12), AINV: 7.71 (+0.15), MCGC: 3.84 (-0.01), TSLX: 17.78 (+0.07), MCC: 9.44 (+0.15), KCAP: 7.04 (+0.09), FDUS: 16.04 (+0.14), PSEC: 8.67 (+0.07), FSIC: 9.49 (+0.03)
3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Jan 10, 1:07PM CST
Source: Flickr via Idaho National Laboratory. Biotech stocks have the uncanny ability to absolutely crush it following a positive clinical or regulatory catalyst. And this trend has been especially pronounced among standout clinical-stage...
BLUE: 90.70 (+0.93), DVAX: 16.96 (+0.66), HTGC: 15.49 (+0.04), NVAX: 8.80 (+0.40), PFE: 34.64 (-0.23), MRK: 58.81 (-0.07), AZN: 69.96 (+0.20), CLDN: 16.45 (-0.05), GSK: 47.94 (+1.99)
Will Hercules Technology's Enhanced Investments Pay Off? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 09, 3:00PM CST
On Jan 5, 2015, we issued an updated research report on Hercules Technology (HTGC).
HTGC: 15.49 (+0.04), FULL: 4.40 (+0.06), ARCC: 16.85 (+0.01), GARS: 14.77 (+0.08)
Cerulean Secures Debt Facility from Hercules Technology Growth Capital of Up to $26.0 Million
Business Wire - Thu Jan 08, 3:00PM CST
Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting(TM), today announced that it has entered into a loan and security agreement with Hercules Technology Growth Capital, Inc. (NYSE:HTGC) for a term loan of up to $26.0 million and completed a private placement for $1.0 million of Cerulean common stock with Hercules.
HTGC: 15.49 (+0.04), CERU: 6.62 (-0.06)
Egalet Acquires/Licenses Two Innovative Approved Pain Products
GlobeNewswire - Thu Jan 08, 7:50AM CST
--Transactions transform Egalet into a commercial specialty pharmaceutical company paving the way for commercialization of late-stage pipeline of abuse-deterrent opioids --
EGLT: 10.60 (+0.58), HTGC: 15.49 (+0.04)
Hercules Technology Growth meets stock trading price conversion requirement for senior notes due 2016
M2 - Thu Jan 08, 4:17AM CST
Speciality finance company Hercules Technology Growth Capital Inc (NYSE:HTGC) disclosed on Thursday that it notified the holders of its 6.00% convertible senior notes due 2016 that the stock trading price conversion requirement was met, during the three months ended 31 December 2014.
HTGC: 15.49 (+0.04)
Hercules Technology Growth Capital Announces the Continued Convertibility of Its 6.00% Convertible Senior Notes Due 2016 Through March 31, 2015
Business Wire - Wed Jan 07, 3:05PM CST
Hercules Technology Growth Capital, Inc. (NYSE:HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology, at all stages of development, today announced that holders of its 6.00% Convertible Senior Notes due 2016 have been notified that the stock trading price conversion requirement was met during the three months ended December 31, 2014.
HTGC: 15.49 (+0.04)
